Author Archives: Steve Bryson PhD

Anxiety and Depression Linked to RRMS Relapse Risk, Study Finds

Comorbidities such as anxiety and depression are associated with a significantly increased risk of relapse in people with relapsing-remitting multiple sclerosis (RRMS), a clinical trial analysis has found.  Anxiety and abnormal blood lipids (fats) also increased the risk of any RRMS disease activity.  Based on those findings, researchers…

More Research Needed Into How Exercise, Rehab Aid Cognition in MS

Cognitive problems are common in people with multiple sclerosis (MS) but inadequately addressed by disease-modifying therapies, while cognitive rehabilitation and exercise training programs can be effective, a review study reported.  Research studies of exercise programs need to include larger groups of patients with demonstrated cognitive difficulties, however, and more pharmacological…

SPMS Triggers and Treatments Among Focus of Expert Panel in Video Series by AJMC

Multiple sclerosis experts discuss disease causes and current treatment options in a new video series released by the multimedia and peer-reviewed science journal, The American Journal of Managed Care.  The free and online video series is part of its “Peer Exchange” initiative, featuring discussions between a panel of opinion leaders representing different therapeutic areas to help guide best practices in disease management.  This series is titled “Identifying Secondary Progressive Multiple Sclerosis,” and features on its panel: Peter L. Salgo, MD, a professor of medicine and anesthesiology at Columbia University Vagelos College of Physicians and Surgeons, and an associate director of surgical intensive care at New York-Presbyterian Hospital (moderator). Patricia K. Coyle, MD, a professor and interim chair of neurology and director of the Multiple Sclerosis Comprehensive Care Center at Stony Brook University. Thomas P. Leist, MD, PhD, director of the Comprehensive Multiple Sclerosis Center at Jefferson University. Maria Lopes, MD, MS, former chief medical officer of Magellan Rx Management. "The panel of experts featured in this educational video series ... will outline secondary progressive MS and all treatment options to achieve the best possible outcomes for patients," Michael J. Hennessy Jr., president of MJH Life Sciences, the parent company of AJMC, said in a press release. The video series begins with an introductory discussion defining MS and various aspects of disease management. Leist opens with a talk about recent advances in understanding the pathology of MS. Previously, he says, “we were thinking of multiple sclerosis largely as a white matter disease [affecting conduction and muscle/motor skills]. Now it’s clearly recognized that pathophysiologically, the more important part, is probably also the gray matter pathology [affecting cognition].” He emphasizes that MS is "a whole brain disease," and that it "affects essentially the functioning of the individual, and multiple sclerosis is not a T-shirt that says ‘One size fits all.’ There is high variability between individuals.” Lopes, in turn, discusses the economic burden of living with MS. She notes that direct costs, such as health plan spending on disease-modifying therapies, are relatively easy to calculate. However, as MS patients “lose function, their employability and productivity start to decrease. And so with that comes indirect costs. The impact on family, on dynamics.” "With a growing prevalence, it’s obviously an exciting time for MS as we link this to more treatment options, but definitely a very high cost disease," Lopes adds. Concerning this economic burden, Coyle mentions that "the National MS Society has estimated the care of MS patients annually costs about $70,000, and in total probably $28 billion a year." In the second video, this same panel of experts discuss whether MS is an autoimmune disease. “I don’t like to call it autoimmune,” says Coyle, “because we’ve never identified an autoantigen target [a molecule that triggers an immune response]. “There’s no doubt that the host immune system is attacking and causing damage within the CNS [central nervous system]. It’s an immune-mediated disease, that’s a definite component. All of our DMTs [disease-modifying therapies] manipulate the immune system, and they are successful,” she adds.   In discussing likely triggers of MS disease, Coyle mentions genetics and environmental factors. As one interesting environmental factor, she says: "for example, there is no adult onset MS case that’s not Epstein-Barr virus [EBV] antibody positive." Panel members also discuss how current research suggests that EBV may trigger MS by infecting immune cells, allowing them to survive beyond their usefulness, leading to autoimmune activation. "It’s a confluence of the genetic makeup of an individual plus what has happened to this individual immunologically. Keep in mind that Epstein-Barr virus, after you acquire it, it is within your body. Where does it survive? Among other things, it survives in B-cells and T-cells ... It gives this T-cell and the B-cell an ever so slight survival advantage," Leist says. "If you have an ever-so-slight survival advantage because of Epstein-Barr virus,” Leist continues, “you may not go away when you should go away, which then leads to an ongoing autoimmune disease or immune activation."  This video series will continue to discuss in detail the various types of MS and treatment options that follow National MS Society recommendations. They will also highlight the importance of early MS treatment, and helpful lifestyle modifications. 

MS Relationships Improved by Togetherness and Communication, Study Suggests

Relationships between multiple sclerosis patients and their intimate partners were enhanced when the couple worked together to make lifestyle changes, and to develop skills to improve communication, a study shows.  The study, "On the path together: Experiences of partners of people with multiple sclerosis of the impact of lifestyle modification on their relationship," was published in the journal Health and Social Care.  People with multiple sclerosis (MS) experience many physical and mental challenges. Further, the unpredictability of the clinical course of the disease can make navigating intimate relationships difficult.  While reports suggest that couples dealing with MS have positive outcomes based on the challenge of facing adversity together, partners of people with MS can experience anxiety, fear, and uncertainty about the diagnosis. They also face challenges with the changes in their relationship roles, as a partner and caregiver.  With declines in the health and well-being of a person with MS, a partner’s physical and mental health-related Quality of Life (HRQOL) also can deteriorate. This can lead to negative outcomes for the couple. There is growing evidence linking changes in lifestyle-related risk factors to improved physical and mental health outcomes. Studies have shown that MS patients who attended intensive workshops teaching evidence-based lifestyle interventions had improved HRQOL, reduced relapse rates, and stabilized disability as determined by the Multiple Sclerosis Impact Scale Physical Component (MSIS‐20).  However, the impact of such lifestyle interventions on the partners of MS patients, and their relationship, has not been evaluated. This prompted researchers to interview partners of a group of MS patients who attended intensive lifestyle modification workshops. The study was guided by the Heidegger's interpretive phenomenology, a philosophy that explores human life experiences in the context of a person’s environment. Researchers interviewed 21 partners of MS patients who had attended lifestyle workshops between 2002 and 2016. The participants were identified in an existing research dataset — the Health Outcomes and Lifestyle In a Sample of people with MS (HOLISM). The interviews were conducted by telephone or Skype by two specialist medical practitioners. Participants lived in Australia, New Zealand, the U.K., and Europe. Among them, 71% were male, 57% were ages 50 or older, and 52% had been in a relationship for more than 20 years. In addition, 52% of the participants had attended the workshop with their MS partner. All relationships were heterosexual.  The lifestyle interventions included changes to diet — to a plant‐based whole food diet, with ultra‐low saturated fat — and regular vigorous exercise for 30 minutes. Participants also employed stress reduction, through meditation or other stress reduction techniques, and sun exposure for vitamin D, or vitamin D supplementation. Smoking cessation also was included in the lifestyle changes. Results identified three main themes regarding the partners’ perspectives on the impact that MS and lifestyle modification had on their relationship as a couple: providing support, remaining connected, and togetherness. On the first theme of providing support, partners of MS patients gave their support in both practical and emotional ways. For instance, the partners encouraged physical endeavors to improve the health of patients. "Making dietary changes along with the person was often the most tangible support they could provide, and partners found making these changes was a way of nurturing their relationship," the researchers said. Some partners reported difficulties in finding a balance between providing support in an acceptable way, while still encouraging the independence of their spouse with MS. Some felt they struggled to provide support in a way that was beneficial in the longer term. Remaining connected — the second theme identified — reflected how partners experienced difficulties in maintaining their relationships. According to the team, understanding the emotions, moods, and behaviors of those with MS required new skills from the partners, and the development of better communication between the couple.  "Some partners expressed difficulties understanding and responding to emotional needs," the researchers said. "They struggled to determine from where the emotions were coming, whether there were reasons related to the illness or related to another cause." Interestingly, partners who attended the lifestyle workshops described improvements in their communication skills, and learning new techniques to openly discuss worries, frustrations, and symptoms.  The final theme — togetherness — was found to be a strong positive topic. The most positive aspects arose by making decisions together regarding lifestyle changes. The teamwork between partners and MS patients was found to be key when undergoing major lifestyle changes. For some couples, exercising together to improve physical fitness led to new common experiences. According to the researchers, working together as a team was seen as helping to ensure the longevity of the relationship by strengthening their bonds. Overall, the team concluded that "for people with MS who undertake lifestyle modification, benefits may be experienced by the partner and the couple. Benefits are obtained through making major changes together, working with unity of purpose towards goals, improved communication, and a resultant sense of closeness and togetherness." The researchers also suggested that "clinicians working with couples with MS should consider the potential benefits of positive lifestyle modification to couples."

Dancing Doodle

Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These flash briefings give our readers an alternative option for accessing information important for them.

Listen Here